Clinical Trial Update: Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update describes Phase 2/3 studies evaluating the use of a proton pump inhibitor to prevent and treat acute fluctuating hearing loss in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonsyndromic Hearing Loss with Enlarged Vestibular Aqueduct
• Pendred Syndrome
• Sensorineural Hearing Loss

Drugs mentioned

• Proton pump inhibitor (PPI) (proton-pump inhibitor)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hearing Loss | Phase 2, Phase 3 | Status: UNKNOWN